Publisher
Springer Berlin Heidelberg
Reference116 articles.
1. Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, Mcllwain HH, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL,Yanover MJ, Leite MO, Siminoski KG, Nevitt MC, Sharp JT, Malice M P, Dumortier T, Czachur M, Carofano W, Daifotis A (2001) Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 44: 202–211
2. Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH (1985) Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 34: 124–129
3. Aloia JF, Vaswani A, Yeh JK, Ross PL, Flaster E, Dilmanian FA (1994) Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 120: 97–103
4. Austin LA, Heath H (1981) Calcitonin: physiology and pathophysiology. N Engl J Med 304: 269–278
5. Bauer W, Aub JC, Albright F (1929) Studies of calcium phosphorus metabolism. V. A study of the bone trabeculae as a readily available reserve supply of calcium. J Exp Med 49: 145–162